ReviewHereditary cancer in clinical practice2017
The potential role of miRNAs in therapy of breast and ovarian cancers associated with BRCA1 mutation.
Agnieszka Strumidło et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this papercites it